Showing posts with label hviid. Show all posts
Showing posts with label hviid. Show all posts

Tuesday 15 September 2015

The Link Between Antidepressants And Autism

The Link Between Antidepressants And Autism.
Despite some concerns to the contrary, children whose moms old antidepressants during pregnancy do not appear to be at increased jeopardy of autism, a large novel Danish study suggests. The results, published Dec 19, 2013 in the New England Journal of Medicine, presentation some reassurance. There have been some hints that antidepressants called picky serotonin reuptake inhibitors (SSRIs) could be linked to autism. SSRIs are the "first-line" drug against depression, and allow for medications such as fluoxetine (Prozac), sertraline (Zoloft), citalopram (Celexa) and paroxetine (Paxil).

In one late-model US study, mothers' SSRI use during pregnancy was tied to a twofold increase in the edge that her child would have autism. A Swedish study saw a similar pattern, though the risk linked to the drugs was smaller. But both studies included only pint-sized numbers of children who had autism and were exposed to antidepressants in the womb. The recent study is "the largest to date" to look at the issue, using records for more than 600000 children born in Denmark, said tether researcher Anders Hviid, of the Statens Serum Institute in Copenhagen.

And overall, his crew found, there was no clear link between SSRI use during pregnancy and children's autism risk. Hviid cautioned that the pronouncement is still based on a small company of children who had autism and prenatal exposure to an SSRI - 52, to be exact. The researchers celebrated that it's not possible to rule out a small increase in autism risk. "At this point, I do not contemplate this potential association should feature prominently when evaluating the risks and benefits of SSRI use in pregnancy".

Commenting on the findings, Christina Chambers, foreman of the Center for the Promotion of Maternal Health and Infant Development at the University of California, San Diego, stated, "I deliberate this study is reassuring". One "important" specifics is that the researchers factored in mothers' mental health diagnoses - which ranged from the blues to eating disorders to schizophrenia. "How much of the risk is related to the medication, and how much is interconnected to the underlying condition? It's hard to tease out".